Local HER-O - Clinical trial • Breast Cancer Foundation NZ

Donate to save lives this Breast Cancer Awareness Month.

Local HER-O

Advanced Breast Cancer clinical trials for HER2+

Updated: July 2, 2020

A phase 2 study of local therapy (stereotactic radiosurgery and/or surgery) for treatment of up to five brain metastases from HER2 positive breast cancer.

This study is looking at the effectiveness of neurosurgery and/or stereotactic radiosurgery (SRS) on tumour management.

Participants will be given either SRS or surgery, or a combination of both depending on the unique features of each tumour. All participants will be followed up at regular three-monthly intervals for 12 months after completing their trial treatment. At each follow-up visit, they'll have a clinic visit with the study doctor who will assess any symptoms, record current medications and/or surgeries, monitor their brain metastasis, and administer a blood test and imaging.

For full trial information


Royal Adelaide Hospital, Adelaide
The Canberra Hospital, Canberra
Peter MacCallum Cancer Centre, Melbourne
The Alfred, Melbourne
Sir Charles Gairdner Hospital, Nedlands
The Crown Princess Mary Cancer Centre, Westmead
Princess Alexandra Hospital, Woolloongabba


Royal Adelaide Hospital: Edlira Dishnica
The Canberra Hospital: Yu-Yan Fang
Peter MacCallum Cancer Centre: Jenny Trinh
The Alfred: Robin Smith
Sir Charles Gairdner Hospital: Aylin Yahya
The Crown Princess Mary Cancer Centre: Kristen Gadsby
Princess Alexandra Hospital: Angela Byron and Mitchell Peters

If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.

Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz

Similar clinical trials

For Advanced Breast Cancer

Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz

Find clinical trials

Interested in a clinical trial?

Subscribe for updates & stay in the loop with new studies.